Improving the Health of Parents & Their Adolescent & Transition-age Youth

Status Recruiting

Clinical Trial Summary

This study will determine the comparative effectiveness of Go Act, a tailored advocacy curriculum versus Peer parent-directed peer learning for increasing parent activation for parents of youth with intellectual and developmental disabilities. Second, it will determine the comparative effectiveness of the two study arms for improving parent and youth health outcomes while assessing whether parent activation serves as a mechanism that mediates their effects on health outcomes.

Clinical Trial Description

A well-functioning system of care should provide a broad array of services that can support families with a child with complex health care needs. Nonetheless, adolescents and transition age youth with intellectual and developmental disabilities experience rates of unmet need for health care up to 6 times higher than others resulting in poor health and quality of life for themselves and their families. The system of care approach has achieved positive impacts for children with intellectual and developmental disabilities and their families, but updates call for training to help parents develop advocacy skills on behalf of their children. Prior research on diverse populations indicates that parent advocacy skills are a promising target for increasing parent self-efficacy, which in turn is associated with better parent and youth health outcomes. Parent advocacy skills can be increased through a psycho-educational advocacy skills curriculum or through parent-directed peer-learning. However, the comparative effectiveness of these two strategies for families raising youth with intellectual and developmental disabilities is not yet known. This study has two objectives. First, it will determine the comparative effectiveness of Go Act, a tailored advocacy curriculum versus Peer parent-directed peer learning for increasing parent activation for parents of youth with intellectual and developmental disabilities . Second, it will determine the comparative effectiveness of the two study arms for improving parent and youth health outcomes while assessing whether parent activation serves as a mechanism that mediates their effects on health outcomes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05986305
Study type	Interventional
Source	University of North Carolina, Chapel Hill
Contact	Kathleen C Thomas, PhD
Phone	9199663387
Email	kathleen_thomas@unc.edu
Status	Recruiting
Phase	N/A
Start date	August 8, 2023
Completion date	March 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05935722` - Evaluation of a Home-based Parenting Support Program: Parenting Young Children	N/A
Completed	`NCT04020302` - Self-Monitoring Shopping Intervention	N/A
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Not yet recruiting	`NCT03644797` - Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs
Not yet recruiting	`NCT02881333` - Various Type of Genetic Events in Patients With Intellectual Disability	N/A
Completed	`NCT03139760` - POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability	N/A
Completed	`NCT02746614` - Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability	N/A
Completed	`NCT06097819` - Therapy-Based Games' Effects on Motor and Cognitive Skills in Intellectual Disabilities	N/A
Recruiting	`NCT05767203` - Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin	N/A
Terminated	`NCT05445596` - Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools	N/A
Recruiting	`NCT05131425` - Facing Your Fears: Adolescents With ASD and Intellectual Disability	N/A
Completed	`NCT04436692` - Dietary Intervention and Adults With Intellectual Disabilities	N/A
Completed	`NCT04917666` - Process and Outcomes of Horticultural Therapy for People With Disabilities	N/A
Completed	`NCT04518358` - Expert Guiding Technology to Help Individuals With Developmental Challenges Build Life and Vocational Skills	N/A
Completed	`NCT04554355` - Effects of a PA Intervention for Fatness and Fitness in Adolescents With Intellectual Disability	N/A
Completed	`NCT04277130` - Effectiveness of Active Video Games in Children With Intellectual Disabilities	N/A
Enrolling by invitation	`NCT02914951` - Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability	N/A
Completed	`NCT02304302` - Down Syndrome Memantine Follow-up Study	Phase 2
Completed	`NCT03989388` - Occupational Self-Analysis Programme	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Improving the Health of Parents and Their Adolescent and Transition-age Youth With Intellectual and Developmental Disabilities

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms